Patrick Scott Coleman MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Physician
Join to View Full Profile
6140 W Curtisian Ave Ste 2006140 W Curtisian Ave Ste 200Boise, ID 83704
Phone+1 208-302-0000
Fax+1 208-302-0055
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Patrick Coleman, MD is a cardiologist in Boise, Idaho. He is currently licensed to practice medicine in Idaho, Oregon, and California.
Education & Training
Tufts Medical CenterFellowship, Cardiovascular Disease, 1989 - 1992
McGaw Medical Center of Northwestern UniversityFellowship, Cardiovascular Disease, 1987 - 1989- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1984 - 1987
- Northwestern University The Feinberg School of MedicineClass of 1984
Certifications & Licensure
ID State Medical License 2020 - 2027
CA State Medical License 1992 - 2026
OR State Medical License 2020 - 2025
IL State Medical License 1984 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 61 citationsThe “Final” 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting StentAjay J. Kirtane, Martin B. Leon, Michael W. Ball, Harpaul S. Bajwa, Michael H. Sketch
JACC. Cardiovascular Interventions. 2013-04-01 - 124 citationsTwo-Year Outcomes After Sirolimus-Eluting Stent Implantation: Results From the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) TrialGiora Weisz, Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Mel R. Clark
Journal of the American College of Cardiology. 2006-04-04 - 48 citationsRandomized, Controlled Dose-Ranging Study of the Selective Adenosine A2A Receptor Agonist Binodenoson for Pharmacological Stress as an Adjunct to Myocardial Perfusion ...James E. Udelson, Gary V. Heller, Frans J. Th. Wackers, Andrew Chai, David A Hinchman
Circulation. 2004-02-03
Press Mentions
NCMA Primary Care Spring Symposium Educational Videos Now Offered OnlineApril 21st, 2017
